Christopher Hupp
Company: Ipsen Pharma
Job title: Senior Director - External Innovation & Chemistry
Seminars:
Panel : Debating Optimal PK/PD Profiles to Carve Out the Optimal Inhibitor for Targeting RAS 1:45 pm
day: Day Two Track A PM
Panel : Debating the Therapeutics Utility of PROTACs & Molecular Glues versus Direct Targeting of RAS to Strategies Best-in-Class Therapeutic Interventions 12:15 pm
day: Day Two Track A AM
TRACK A: Drug Discovery & Pre-Clinical Development 11:00 am
day: Day Two Track A AM
TRACK A: Drug Discovery & Pre-Clinical Development 11:00 am
day: Day One Track A AM